2023
DOI: 10.1002/jper.22-0556
|View full text |Cite|
|
Sign up to set email alerts
|

Salivary cytokine expression after non‐surgical periodontal therapy in smokers: 12‐month follow‐up

Abstract: Background Diverse smoking trajectories may influence cytokine expression after non‐surgical periodontal therapy and supportive periodontal care. Thus, we aimed to describe cytokine profiles in periodontal healing after periodontal therapy in smokers. Methods A smoking cessation program and non‐surgical periodontal therapy were offered to 80 smokers with periodontitis. Smoking trajectories (quitters/light, moderate, heavy) were observed. The association of salivary interleukin (IL)‐1β, IL‐2, IL‐4, IL‐6, IL‐8, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 49 publications
0
2
0
Order By: Relevance
“…We hypothesize that at baseline (T0) higher levels of serum cytokines are observed in smokers with periodontitis compared with non-smokers with periodontitis and with decreasing intergroup differences along therapy (at T1 and T2). As levels of IL-8 and IL-6 appears to be impacted by heavy smoking following periodontal therapy [ 3 , 22 ] the aims of this prospective cohort study were to determine the influence of smoking on the presence and level of serum inflammatory markers and clinical measures in smokers with stage III and IV periodontitis, and to compare levels of serum cytokines in smokers and non-smokers following step I-III and 12-month step IV periodontal therapy, with particular emphasis on IL-6 and IL-8.…”
Section: Introductionmentioning
confidence: 99%
“…We hypothesize that at baseline (T0) higher levels of serum cytokines are observed in smokers with periodontitis compared with non-smokers with periodontitis and with decreasing intergroup differences along therapy (at T1 and T2). As levels of IL-8 and IL-6 appears to be impacted by heavy smoking following periodontal therapy [ 3 , 22 ] the aims of this prospective cohort study were to determine the influence of smoking on the presence and level of serum inflammatory markers and clinical measures in smokers with stage III and IV periodontitis, and to compare levels of serum cytokines in smokers and non-smokers following step I-III and 12-month step IV periodontal therapy, with particular emphasis on IL-6 and IL-8.…”
Section: Introductionmentioning
confidence: 99%
“…Published by Francis Academic Press, UK -29-achieve a more personalized treatment plan in the future, bringing new hope for cancer patients [1][2].…”
mentioning
confidence: 99%